USD $30.60-36.10 / Gram
lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
product name: | 2-methylindole-3-ethylamine |
synonyms: | art-chem-bb b006949;2-methylindole-3-ethylamine;2-methyl tryptamine;3-(2-aminoethyl)-2-methylindole;2-(2-methyl-1h-indol-3-yl)ethanamine;2-(2-methyl-1h-indol-3-yl)-ethylamine;akos b006949;rarechem an ka 1106 |
cas: | 2731-06-8 |
mf: | c11h14n2 |
mw: | 174.24 |
einecs: | 220-347-3 |
product categories: | amines;aromatics;intermediates & fine chemicals;pharmaceuticals;heterocycles |
mol file: | 2731-06-8.mol |
2-methylindole-3-ethylamine chemical properties |
cas database reference | 2731-06-8(cas database reference) |
safety information |
hazard codes | xi |
hazardclass | irritant |
2-methylindole-3-ethylamine usage and synthesis |
chemical properties | brown solid |
usage | key starting material in the synthesis of the histone deacetylase inhibitor lbh589. |
2-methylindole-3-ethylamine preparation products and raw materials |